Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

81
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
81
Blood Transfusion01:15

Blood Transfusion

820
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
820
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

11.3K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.3K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

166
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
166
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

38
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
38
Two-Compartment Open Model: IV Infusion01:15

Two-Compartment Open Model: IV Infusion

339
A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
339

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epinephrine Is the Preferred Vasopressor After Return of Spontaneous Circulation Following Cardiac Arrest.

Annals of emergency medicine·2026
Same author

Rates of Recommended Shingles Vaccination and Interest Among Emergency Department Patients: A Multicenter Study.

Annals of emergency medicine·2025
Same author

Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED Study.

Annals of emergency medicine·2024
Same author

Empirical antimicrobial prescribing for pyelonephritis in patients discharged from 15 US Emergency Departments: an opportunity for improvement.

The Journal of antimicrobial chemotherapy·2024
Same author

Process Simulation and Optimization on Ionic Liquids.

Chemical reviews·2024
Same author

High prevalence of fluoroquinolone-resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018-2020.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine·2022

Related Experiment Video

Updated: Sep 17, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.7K

Resuscitating massive transfusion knowledge: An update for the pharmacist.

Ruben Santiago1, Giles Slocum2, Gina Riggi1

  • 1Jackson Memorial Hospital, Miami, FL, USA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|June 28, 2025
PubMed
Summary

Massive transfusion, defined as 10+ red blood cell units in 24 hours, is a critical emergency treatment for hemorrhage. Clinical pharmacists play a vital role in managing its complications and adjunctive medications.

Keywords:
hemorrhagic shockmassive transfusionresuscitationthromboelastographytranexamic acidtrauma

More Related Videos

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

7.9K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.6K

Related Experiment Videos

Last Updated: Sep 17, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.7K
Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

7.9K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.6K

Area of Science:

  • Critical care medicine
  • Hematology
  • Clinical pharmacy

Background:

  • Hemorrhage is a frequent complication of traumatic injuries, necessitating blood product resuscitation.
  • Massive transfusion protocols are often implemented for patients experiencing severe bleeding.

Purpose of the Study:

  • To review the indications for massive transfusion.
  • To detail the components and common ratios of blood products used.
  • To outline potential complications and adjunctive medications, emphasizing clinical pharmacist implications.

Main Methods:

  • Literature review of massive transfusion protocols and related pharmacotherapy.
  • Analysis of definitions, indications, and complications.
  • Exploration of the role of pharmacists in massive transfusion management.

Main Results:

  • Massive transfusion involves administering blood products to acutely hemorrhaging patients, commonly defined as ≥10 red blood cell units/24 hours.
  • Potential complications include electrolyte disturbances and cardiopulmonary reactions.
  • Adjunctive therapies like intravenous calcium and tranexamic acid may be indicated.

Conclusions:

  • Massive transfusion is a life-saving intervention requiring precise management of blood products and potential complications.
  • Pharmacists are integral to resuscitation efforts, needing expertise in managing complications and utilizing adjunctive pharmacotherapy.